The current study shows that COL1A2, followed by TIMP-1, are the most potent CAF-markers found and verified at the transcriptome and protein level across multiple CAF types, differentiating CAF from tumour epithelia and normal fibroblast in HNSC patient samples. This evidence concerns the gene TIMP1 and neoplasm.